ArticleNature genetics2018
Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh.
Abstract read
In one paragraph
Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases From Household Microbiological and Clinical Data.The Journal of infectious diseases · 2026Article
- Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases from Household Microbiological and Clinical Data.medRxiv : the preprint server for health sciences · 2026Article
- Vibrio cholerae motility is associated with inter-animal transmission.Nature communications · 2025Article
- Article
- Allelic variations and gene cluster modularity act as nonlinear bottlenecks for cholera emergence.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Prevalence and antimicrobial susceptibility pattern of Vibrio cholerae isolates from cholera outbreak sites in Ethiopia.BMC public health · 2024Article
- Genomic epidemiology of Vibrio cholerae during a mass vaccination campaign of displaced communities in Bangladesh.Nature communications · 2023Article
- Genome Sequences from a Reemergence of Vibrio cholerae in Haiti, 2022 Reveal Relatedness to Previously Circulating Strains.Journal of clinical microbiology · 2023Article
- Implementation of targeted cholera response activities, Cameroon.Bulletin of the World Health Organization · 2023Article
- Review
- The potential of genomics for infectious disease forecasting.Nature microbiology · 2022Review
- Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic.Nature communications · 2022Article
- Population genomics of Escherichia coli in livestock-keeping households across a rapidly developing urban landscape.Nature microbiology · 2022Article
- Article
- A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients.mSystems · 2021Article
- Genomics of the Argentinian cholera epidemic elucidate the contrasting dynamics of epidemic and endemic Vibrio cholerae.Nature communications · 2020Article
- Challenges of Testing COVID-19 Cases in Bangladesh.International journal of environmental research and public health · 2020Article
- Article
- Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.PLoS neglected tropical diseases · 2020Article
- Genomic epidemiology of Vibrio cholerae reveals the regional and global spread of two epidemic non-toxigenic lineages.PLoS neglected tropical diseases · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Daryl DommanInfection Genomics Programme, Wellcome Sanger Institute, Hinxton, UK. daryl.domman@sanger.ac.uk.ORCID http://orcid.org/0000-0001-5389-9185
Fahima ChowdhuryInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Ashraful I KhanInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Matthew J DormanInfection Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-7064-6163
Ankur MutrejaInfection Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.
Muhammad Ikhtear UddinInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Anik PaulInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Yasmin A BegumInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Richelle C CharlesDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Stephen B CalderwoodDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Taufiqur R BhuiyanInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Jason B HarrisDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Regina C LaRocqueDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Edward T RyanDivision of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Firdausi QadriInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Nicholas R ThomsonInfection Genomics Programme, Wellcome Sanger Institute, Hinxton, UK. nrt@sanger.ac.uk.
Funding
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3MProtecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8MHigh throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine developmentU01AI077883 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2008 to 2012
$5.6MTraining program in vaccine development and public healthD43TW005572 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI QADRI, FIRDAUSI, RYAN, EDWARD T. · 2000 to 2025
$5.4MO-Specific Polysaccharide Responses and CholeraR37AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Edward T. Ryan · 2020 to 2026
$5.1MInnate and early B cell responses to V. choleraeR01AI103055 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B · 2014 to 2018
$3.9MO-Specific Polysaccharide Responses and CholeraR01AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2014 to 2018
$3.7MO-Specific Polysaccharide Responses and CholeraR56AI106878 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2013 to 2020
$843kHumoral and adaptive immune responses study in Vibrio cholerae infectionK43TW010362 · FIC · INTERNATIONAL CTR/DIARRHOEAL DIS RES · PI BHUIYAN, MD TAUFIQUR RAHMAN · 2016 to 2020
$359kFIC NIH HHS D43 TW005572FIC NIH HHS K43 TW010362NIAID NIH HHS R01 AI103055NIAID NIH HHS R01 AI106878NIAID NIH HHS R37 AI106878NIAID NIH HHS R56 AI106878NIAID NIH HHS U01 AI058935NIAID NIH HHS U01 AI077883NIDDK NIH HHS P30 DK043351Wellcome Trust
Abstract
Although much focus is placed on cholera epidemics, the greatest burden occurs in settings in which cholera is endemic, including areas of South Asia, Africa and now Haiti
Indexed as
AfricaAsiaBangladeshCholeraDisease OutbreaksGenome, BacterialGenomicsHumansPhylogenyVibrio cholerae
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.